The Indian Council of Medical Research (ICMR), which collaborated in developing the Covid-19 vaccine, said the issue is between the WHO and...

According to a statement issued by the National Health Surveillance Agency of Brazil, Anvisa its Collegiate Board on Tuesday took a decisio...

“The Coordination of Clinical Research at Anvisa (Copec/GGMED) determined this Friday (23/7) the precautionary suspension of clinical studi...

Bharat Biotech said it has followed a widely accepted ‘step-by-step’ approach towards contracts and regulatory approvals in Brazil and not ...

Brazil's Health minister Queiroga said his ministry is going to carry out an administrative investigation to verify all aspects of the issu...

There were several red flags, according to Miranda, who testified Friday before a Senate panel investigating the government's handling of t...

The CoWin portal to book vaccination slots doesn’t reflect the Uttar Pradesh government's decision to reserve vaccines for the 18-44 age gr...

The vaccine, which is currently undergoing phase-3 clinical trials, is likely to be available in the next few months, the health ministry s...

In the EOI, the Directorate General of Health Services (DGHS) stated that the offered vaccine must be duly approved by a competent authorit...

The scrip jumped 14 per cent to Rs 3,099 in early deals, but gave up some of those gains to trade at Rs 2,914.75 at 11:00 am.

"The company plans to produce 200 million doses of Covaxin per annum in the GMP facilities that are already operational for the production ...

Poonawalla sold 3.15 million shares of Panacea Biotech at Rs 373.85 per share to Serum Institute in a block deal on the BSE earlier today.

Explaining the need for a BSL-3 facility to make Covaxin, Dr Rakesh K Mishra, former director and now advisor of Centre for Cellular and Mo...

The Maharashtra government had sought permission from the centre in March seeking the Centre’s nod in getting Haffkine to have a deal with ...

Experts have called upon both companies to ramp up production and have asked the government to approve the use of more vaccines in the coun...

Hyderabad, Telangana has still not rolled out Covaxin, developed by Hyderabad-based Bharat Biotech, apparently due to fact that the Centre ...

Administering Bharat Biotech's COVAXIN, a move cheered by nationalist politicians, has worried some health experts who consider it rushed, ...